Source: International Congress 2019 – Managing drug-resistant tuberculosis: from new guidelines to clinical practice
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. Migliori (Varese (VA), Italy). The new ATS/ERS/IDSA/CDC guidelines for MDR-TB: rationale, methods and recommendations. International Congress 2019 – Managing drug-resistant tuberculosis: from new guidelines to clinical practice

Member's Comments

No comment yet.

Related content which might interest you: HAP/VAP : new guidelines, new approaches Source: International Congress 2018 – Chinese Programme 2018: Part II Year: 2018 Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 ERS guidelines: treatment options and recommendations Source: International Congress 2019 – Guidelines for long-term non-invasive ventilation in chronic obstructive pulmonary disease Year: 2019 How do the new guidelines work? Practical approach to the new guidelines for asthma diagnosis in children, discussion and Q&A Source: Virtual Congress 2021 – The ERS guidelines for the diagnosis of asthma in children aged 5-16 years Year: 2021 2015 guidelines to treat IPF: an update of the 2011 guidelines - specific treatment recommendations Source: International Congress 2015 – Treatment of idiopathic pulmonary fibrosis Year: 2015 The new ATS and ERS TB treatment guidelines Source: International Congress 2016 – ERS and tuberculosis Year: 2016 MDR-TB guidelines: what is new on clinical management Source: ERS Webinar 2020: MDR-TB guidelines: what is new on clinical management Year: 2020 How to apply evidence based practice critique method to review of guidelines Source: Annual Congress 2005 - Workshop: evidence-based practice: an approach to care Year: 2005 Tuberculosis: update on new diagnostic methods and treatment approach Source: Annual Congress 2007 - Infections year in review Year: 2007 Are TB services in England adhering to new NICE guidelines on screening for latent TB? Source: International Congress 2017 – Migrants and screening Year: 2017 The use of ß2-adrenoreceptor agonists in viral bronchiolitis: scientific rationale beyond evidence-based guidelines Source: ERJ Open Res, 6 (4) 00135-2020; 10.1183/23120541.00135-2020 Year: 2020 Formulating recommendations and identifying areas of future research - Panel discussion and protocol Source: Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs) Year: 2009 The WHO Guidelines for the Programmatic Management of drug-resistant TB: the 2011 update - recommendations and evidence Source: Annual Congress 2011 - ECDC and WHO tuberculosis guidelines: update 2011 (organised within the FP7 funded TB-PAN-NET project) Year: 2011 WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update Source: Eur Respir J 2011; 38: 516-528 Year: 2011 Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultation Source: Eur Respir J 2014; 44: 1412-1417 Year: 2014 Adaptation rate between COPD treatment in clinical practice and guidelines recommendations Source: Eur Respir J 2007; 30: Suppl. 51, 779s Year: 2007